Open Peer Review Reports for: Oxaliplatin plus leucovorin and 5-fluorouracil (FOLFOX-4) as a salvage chemotherapy in heavily-pretreated platinum-resistant ovarian cancer
Pre-publication versions of this article are available by contacting info@biomedcentral.com.
| Original Submission | ||
|---|---|---|
| 14 Sep 2018 | Submitted | Original manuscript |
| 14 Oct 2018 | Reviewed | Reviewer Report - Robert Wenham |
| 20 Nov 2018 | Reviewed | Reviewer Report - Elsa Kalbacher |
| 26 Nov 2018 | Author responded | Author comments - Vincenza Conteduca |
| Resubmission - Version 2 | ||
| 26 Nov 2018 | Submitted | Manuscript version 2 |
| 28 Nov 2018 | Author responded | Author comments - Vincenza Conteduca |
| Resubmission - Version 3 | ||
| 28 Nov 2018 | Submitted | Manuscript version 3 |
| 3 Dec 2018 | Author responded | Author comments - Vincenza Conteduca |
| Resubmission - Version 4 | ||
| 3 Dec 2018 | Submitted | Manuscript version 4 |
| Publishing | ||
| 4 Dec 2018 | Editorially accepted | |
| 19 Dec 2018 | Article published | 10.1186/s12885-018-5180-1 |
How does Open Peer Review work?
Open peer review is a system where authors know who the reviewers are, and the reviewers know who the authors are. If the manuscript is accepted, the named reviewer reports are published alongside the article. Pre-publication versions of the article are available by contacting info@biomedcentral.com.
You can find further information about the peer review system here.
